Ahmed M. Al-Rawi

Statistics

Publications

Citations

101

H-Index

Active since

2022

Affiliations

University of Sharjah(Current)

Mansoura University

Mayo Clinic in Florida

Ahmed M. Al-Rawi is an author at University of Sharjah specializing in sodium-glucose cotransporter 2 inhibitors, inflammation in cardiovascular disease, and life sciences.

ORCID

Publications per year

2022–2024

Publications

Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cells

Fatmah R. Alsereidi, Zenith Khashim, Hezlin Marzook et al. · Cardiovascular Diabetology · 2024 · 50 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement

Fatmah R. Alsereidi, Zenith Khashim, Hezlin Marzook et al. · Current Problems in Cardiology · 2024 · 40 citations

Medicine, Cardiology, Pharmacology +12

Novel Secreted Peptides From Rhizopus arrhizus var. delemar With Immunomodulatory Effects That Enhance Fungal Pathogenesis

Sameh S. M. Soliman, Eman M. El‐labbad, Ameera Abu-Qiyas et al. · Frontiers in Microbiology · 2022 · 11 citations · Full text

Life Sciences, Immunology, Microbiology +17

1–3 of 3